Preserve your uterus with scarless procedure
Imagine a life without fibroids!
Transforming women's health through empathetic innovation
Problem
Uterine fibroids are non-cancerous tumors affecting 1 in 4 women globally, causing substantial quality of life issues. Economic burden globally is about $34 Billion.
What we do
ABOUT
Nesa Medtech's mission is to transform women’s health by developing a revolutionary minimally invasive surgical solutions by pursuing innovation through technology while adhering to global quality standards with support of a multi disciplinary and experienced team.
Nesa’s flagship product GYIDE is a novel minimally invasive, safe, effective and uterus-preserving technology to treat uterine fibroids.
Existing Solutions - Invasive or Inaccessible
Gynecologist
Cutting & Suturing
Longer Recovery
Operation Theater
Interventional Radiologist
No Cut & Suture
Longer Procedure Time
Expensive Infrastructure
Surgical
Non-Surgical
Our Solution
GYIDE addresses the primary concern of key stakeholders and offers an effective alternative to current solutions.
Our innovative technology is a precise guidance and planning system to deliver treatment to shrink uterine fibroids leading to symptomatic relief.
Revolutionary scarless technology to treat uterine fibroids.
Faster Recovery
Less Procedure Time
No Cut, No Suturing
Uterus Preservation
Strong and Prolonged
Menstruation
Severe Abdominal
Pain
Infertility
Primary Symptom Heavy menstrual bleeding²
Waiting time to seek treatment¹
Employed women missed work¹
1. Bijan J, Borah. Am J Obstet Gynecol 2013 Oct 209(4):319.e1-319.e2 2. De La Cruz MS, Buchana EM. Am Fam Physician 2017;95(2) 100-107